Facial Fat Transfer Comprehensive Study by Type (Microfat Grafting, Nanofat Grafting, Structural Fat Grafting), Application (Hospitals and Surgical Centres, Dermatological Clinics), Targeted Site (Lips, Temples, Chin, Under-Eye Area, Marionette Folds, Naso-Labial Folds), Donor Site (Abdomen, Thigh, Buttocks, Others) Players and Region - Global Market Outlook to 2028

Facial Fat Transfer Market by XX Submarkets | Forecast Years 2023-2028  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Facial Fat Transfer Market Scope
Facial Fat Transfer is also known as face grafting, this used to refresh and uplift the face. In this procedure with the helped of cannula fat is removed from the donor part of body, after that removed fat is treated in centrifuge than later on skilled dermatologist inject treated fat into the targeted site on face. Recent advancement in this sector, give birth to new technique and equipment’s for used according to priority. Facial fat transfer is more likely favoured by the people with skin conditions such as sagging, dull, wants to improve skin scarring and skin perfection. Higher demand of facial fat transfer in middle age people and increasing awareness about skin aesthetics give drive to the facial fat transfer market.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledAllergen (Ireland), Ranfac Corp. (United States), Galderma (Switzerland), Cytori therapeutics (United States), Medikan International Inc. (United States), Alma Laser (Israel), MediNordic (Denmark), Human Med AG (Germany), Sinclair Pharma (United Kingdom) and DMS Biotech (United States)
CAGR%


Facial Fat Transfer market is a consolidated market due to the presence of few players. Companies are focusing on developing innovative products and solutions to improve quality, enhances and promotes performance, along with try to incorporate latest technology. The companies are coming up with partnerships or agreements along with planning strategic activities such as partnerships, product launch, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Facial Fat Transfer market throughout the predicted period.

Allergen (Ireland), Ranfac Corp. (United States), Galderma (Switzerland), Cytori therapeutics (United States), Medikan International Inc. (United States), Alma Laser (Israel), MediNordic (Denmark), Human Med AG (Germany), Sinclair Pharma (United Kingdom) and DMS Biotech (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Anthony Products, Inc. (United States), Genesis Biosystems, Inc. (United States) and Integra LifeSciences Corporation (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Facial Fat Transfer market by Type , by Application (Hospitals and Surgical Centres and Dermatological Clinics) and Region with country level break-up.

On the basis of geography, the market of Facial Fat Transfer has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2022.

In January 2023, Galderma launched FACE augmented reality application. This is useful for aesthetic practitioners and patients to envision treatment results in the initial stage of treatment. this application evaluate the face if patient based on kin quality, facial shape, facial symmetry, facial proportions, and contour, as well as animation and emotional expression. This launch helped Galderma to expand its presence in facial fat transfer market.


Influencing Trend:
High demand for Facial Fat Transfer for aesthetic purpose

Market Growth Drivers:
Increasing Demand for Facial Fat Transfer in Thirty Age and Older Population, Surge for Face Countering As a Fastest Growing Cosmetic Procedure, Higher Request for Non-Invasive Procedure and Dermatologist Inclined Towards Learning Facial Fat Transfer Procedures

Challenges:
High Chances for Bacterial Skin Infection

Restraints:
Increasing incidence of death of patient and several fatal side effects after Facial Fat Transfer Procedures

Opportunities:
Increasing Technical Advancement Such As Nano-Fat Graft Technology

Key Target Audience
Facial Fat Transfer Device Manufacturers, Distributors, Regulatory Bodies, Potential Investors, Research and Development Institutes, End Users and Others

Report Objectives / Segmentation Covered

By Type
  • Microfat Grafting
  • Nanofat Grafting
  • Structural Fat Grafting
By Application
  • Hospitals and Surgical Centres
  • Dermatological Clinics
By Targeted Site
  • Lips
  • Temples
  • Chin
  • Under-Eye Area
  • Marionette Folds
  • Naso-Labial Folds

By Donor Site
  • Abdomen
  • Thigh
  • Buttocks
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Demand for Facial Fat Transfer in Thirty Age and Older Population
      • 3.2.2. Surge for Face Countering As a Fastest Growing Cosmetic Procedure
      • 3.2.3. Higher Request for Non-Invasive Procedure
      • 3.2.4. Dermatologist Inclined Towards Learning Facial Fat Transfer Procedures
    • 3.3. Market Challenges
      • 3.3.1. High Chances for Bacterial Skin Infection
    • 3.4. Market Trends
      • 3.4.1. High demand for Facial Fat Transfer for aesthetic purpose
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Facial Fat Transfer, by Type, Application, Targeted Site , Donor Site and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Facial Fat Transfer (Value)
      • 5.2.1. Global Facial Fat Transfer by: Type (Value)
        • 5.2.1.1. Microfat Grafting
        • 5.2.1.2. Nanofat Grafting
        • 5.2.1.3. Structural Fat Grafting
      • 5.2.2. Global Facial Fat Transfer by: Application (Value)
        • 5.2.2.1. Hospitals and Surgical Centres
        • 5.2.2.2. Dermatological Clinics
      • 5.2.3. Global Facial Fat Transfer Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Facial Fat Transfer: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Allergen (Ireland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Ranfac Corp. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Galderma (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cytori therapeutics (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Medikan International Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Alma Laser (Israel)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. MediNordic (Denmark)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Human Med AG (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sinclair Pharma (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. DMS Biotech (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Facial Fat Transfer Sale, by Type, Application, Targeted Site , Donor Site and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Facial Fat Transfer (Value)
      • 7.2.1. Global Facial Fat Transfer by: Type (Value)
        • 7.2.1.1. Microfat Grafting
        • 7.2.1.2. Nanofat Grafting
        • 7.2.1.3. Structural Fat Grafting
      • 7.2.2. Global Facial Fat Transfer by: Application (Value)
        • 7.2.2.1. Hospitals and Surgical Centres
        • 7.2.2.2. Dermatological Clinics
      • 7.2.3. Global Facial Fat Transfer Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Facial Fat Transfer: by Type(USD Million)
  • Table 2. Facial Fat Transfer Microfat Grafting , by Region USD Million (2017-2022)
  • Table 3. Facial Fat Transfer Nanofat Grafting , by Region USD Million (2017-2022)
  • Table 4. Facial Fat Transfer Structural Fat Grafting , by Region USD Million (2017-2022)
  • Table 5. Facial Fat Transfer: by Application(USD Million)
  • Table 6. Facial Fat Transfer Hospitals and Surgical Centres , by Region USD Million (2017-2022)
  • Table 7. Facial Fat Transfer Dermatological Clinics , by Region USD Million (2017-2022)
  • Table 8. South America Facial Fat Transfer, by Country USD Million (2017-2022)
  • Table 9. South America Facial Fat Transfer, by Type USD Million (2017-2022)
  • Table 10. South America Facial Fat Transfer, by Application USD Million (2017-2022)
  • Table 11. South America Facial Fat Transfer, by Targeted Site USD Million (2017-2022)
  • Table 12. South America Facial Fat Transfer, by Donor Site USD Million (2017-2022)
  • Table 13. Brazil Facial Fat Transfer, by Type USD Million (2017-2022)
  • Table 14. Brazil Facial Fat Transfer, by Application USD Million (2017-2022)
  • Table 15. Brazil Facial Fat Transfer, by Targeted Site USD Million (2017-2022)
  • Table 16. Brazil Facial Fat Transfer, by Donor Site USD Million (2017-2022)
  • Table 17. Argentina Facial Fat Transfer, by Type USD Million (2017-2022)
  • Table 18. Argentina Facial Fat Transfer, by Application USD Million (2017-2022)
  • Table 19. Argentina Facial Fat Transfer, by Targeted Site USD Million (2017-2022)
  • Table 20. Argentina Facial Fat Transfer, by Donor Site USD Million (2017-2022)
  • Table 21. Rest of South America Facial Fat Transfer, by Type USD Million (2017-2022)
  • Table 22. Rest of South America Facial Fat Transfer, by Application USD Million (2017-2022)
  • Table 23. Rest of South America Facial Fat Transfer, by Targeted Site USD Million (2017-2022)
  • Table 24. Rest of South America Facial Fat Transfer, by Donor Site USD Million (2017-2022)
  • Table 25. Asia Pacific Facial Fat Transfer, by Country USD Million (2017-2022)
  • Table 26. Asia Pacific Facial Fat Transfer, by Type USD Million (2017-2022)
  • Table 27. Asia Pacific Facial Fat Transfer, by Application USD Million (2017-2022)
  • Table 28. Asia Pacific Facial Fat Transfer, by Targeted Site USD Million (2017-2022)
  • Table 29. Asia Pacific Facial Fat Transfer, by Donor Site USD Million (2017-2022)
  • Table 30. China Facial Fat Transfer, by Type USD Million (2017-2022)
  • Table 31. China Facial Fat Transfer, by Application USD Million (2017-2022)
  • Table 32. China Facial Fat Transfer, by Targeted Site USD Million (2017-2022)
  • Table 33. China Facial Fat Transfer, by Donor Site USD Million (2017-2022)
  • Table 34. Japan Facial Fat Transfer, by Type USD Million (2017-2022)
  • Table 35. Japan Facial Fat Transfer, by Application USD Million (2017-2022)
  • Table 36. Japan Facial Fat Transfer, by Targeted Site USD Million (2017-2022)
  • Table 37. Japan Facial Fat Transfer, by Donor Site USD Million (2017-2022)
  • Table 38. India Facial Fat Transfer, by Type USD Million (2017-2022)
  • Table 39. India Facial Fat Transfer, by Application USD Million (2017-2022)
  • Table 40. India Facial Fat Transfer, by Targeted Site USD Million (2017-2022)
  • Table 41. India Facial Fat Transfer, by Donor Site USD Million (2017-2022)
  • Table 42. South Korea Facial Fat Transfer, by Type USD Million (2017-2022)
  • Table 43. South Korea Facial Fat Transfer, by Application USD Million (2017-2022)
  • Table 44. South Korea Facial Fat Transfer, by Targeted Site USD Million (2017-2022)
  • Table 45. South Korea Facial Fat Transfer, by Donor Site USD Million (2017-2022)
  • Table 46. Taiwan Facial Fat Transfer, by Type USD Million (2017-2022)
  • Table 47. Taiwan Facial Fat Transfer, by Application USD Million (2017-2022)
  • Table 48. Taiwan Facial Fat Transfer, by Targeted Site USD Million (2017-2022)
  • Table 49. Taiwan Facial Fat Transfer, by Donor Site USD Million (2017-2022)
  • Table 50. Australia Facial Fat Transfer, by Type USD Million (2017-2022)
  • Table 51. Australia Facial Fat Transfer, by Application USD Million (2017-2022)
  • Table 52. Australia Facial Fat Transfer, by Targeted Site USD Million (2017-2022)
  • Table 53. Australia Facial Fat Transfer, by Donor Site USD Million (2017-2022)
  • Table 54. Rest of Asia-Pacific Facial Fat Transfer, by Type USD Million (2017-2022)
  • Table 55. Rest of Asia-Pacific Facial Fat Transfer, by Application USD Million (2017-2022)
  • Table 56. Rest of Asia-Pacific Facial Fat Transfer, by Targeted Site USD Million (2017-2022)
  • Table 57. Rest of Asia-Pacific Facial Fat Transfer, by Donor Site USD Million (2017-2022)
  • Table 58. Europe Facial Fat Transfer, by Country USD Million (2017-2022)
  • Table 59. Europe Facial Fat Transfer, by Type USD Million (2017-2022)
  • Table 60. Europe Facial Fat Transfer, by Application USD Million (2017-2022)
  • Table 61. Europe Facial Fat Transfer, by Targeted Site USD Million (2017-2022)
  • Table 62. Europe Facial Fat Transfer, by Donor Site USD Million (2017-2022)
  • Table 63. Germany Facial Fat Transfer, by Type USD Million (2017-2022)
  • Table 64. Germany Facial Fat Transfer, by Application USD Million (2017-2022)
  • Table 65. Germany Facial Fat Transfer, by Targeted Site USD Million (2017-2022)
  • Table 66. Germany Facial Fat Transfer, by Donor Site USD Million (2017-2022)
  • Table 67. France Facial Fat Transfer, by Type USD Million (2017-2022)
  • Table 68. France Facial Fat Transfer, by Application USD Million (2017-2022)
  • Table 69. France Facial Fat Transfer, by Targeted Site USD Million (2017-2022)
  • Table 70. France Facial Fat Transfer, by Donor Site USD Million (2017-2022)
  • Table 71. Italy Facial Fat Transfer, by Type USD Million (2017-2022)
  • Table 72. Italy Facial Fat Transfer, by Application USD Million (2017-2022)
  • Table 73. Italy Facial Fat Transfer, by Targeted Site USD Million (2017-2022)
  • Table 74. Italy Facial Fat Transfer, by Donor Site USD Million (2017-2022)
  • Table 75. United Kingdom Facial Fat Transfer, by Type USD Million (2017-2022)
  • Table 76. United Kingdom Facial Fat Transfer, by Application USD Million (2017-2022)
  • Table 77. United Kingdom Facial Fat Transfer, by Targeted Site USD Million (2017-2022)
  • Table 78. United Kingdom Facial Fat Transfer, by Donor Site USD Million (2017-2022)
  • Table 79. Netherlands Facial Fat Transfer, by Type USD Million (2017-2022)
  • Table 80. Netherlands Facial Fat Transfer, by Application USD Million (2017-2022)
  • Table 81. Netherlands Facial Fat Transfer, by Targeted Site USD Million (2017-2022)
  • Table 82. Netherlands Facial Fat Transfer, by Donor Site USD Million (2017-2022)
  • Table 83. Rest of Europe Facial Fat Transfer, by Type USD Million (2017-2022)
  • Table 84. Rest of Europe Facial Fat Transfer, by Application USD Million (2017-2022)
  • Table 85. Rest of Europe Facial Fat Transfer, by Targeted Site USD Million (2017-2022)
  • Table 86. Rest of Europe Facial Fat Transfer, by Donor Site USD Million (2017-2022)
  • Table 87. MEA Facial Fat Transfer, by Country USD Million (2017-2022)
  • Table 88. MEA Facial Fat Transfer, by Type USD Million (2017-2022)
  • Table 89. MEA Facial Fat Transfer, by Application USD Million (2017-2022)
  • Table 90. MEA Facial Fat Transfer, by Targeted Site USD Million (2017-2022)
  • Table 91. MEA Facial Fat Transfer, by Donor Site USD Million (2017-2022)
  • Table 92. Middle East Facial Fat Transfer, by Type USD Million (2017-2022)
  • Table 93. Middle East Facial Fat Transfer, by Application USD Million (2017-2022)
  • Table 94. Middle East Facial Fat Transfer, by Targeted Site USD Million (2017-2022)
  • Table 95. Middle East Facial Fat Transfer, by Donor Site USD Million (2017-2022)
  • Table 96. Africa Facial Fat Transfer, by Type USD Million (2017-2022)
  • Table 97. Africa Facial Fat Transfer, by Application USD Million (2017-2022)
  • Table 98. Africa Facial Fat Transfer, by Targeted Site USD Million (2017-2022)
  • Table 99. Africa Facial Fat Transfer, by Donor Site USD Million (2017-2022)
  • Table 100. North America Facial Fat Transfer, by Country USD Million (2017-2022)
  • Table 101. North America Facial Fat Transfer, by Type USD Million (2017-2022)
  • Table 102. North America Facial Fat Transfer, by Application USD Million (2017-2022)
  • Table 103. North America Facial Fat Transfer, by Targeted Site USD Million (2017-2022)
  • Table 104. North America Facial Fat Transfer, by Donor Site USD Million (2017-2022)
  • Table 105. United States Facial Fat Transfer, by Type USD Million (2017-2022)
  • Table 106. United States Facial Fat Transfer, by Application USD Million (2017-2022)
  • Table 107. United States Facial Fat Transfer, by Targeted Site USD Million (2017-2022)
  • Table 108. United States Facial Fat Transfer, by Donor Site USD Million (2017-2022)
  • Table 109. Canada Facial Fat Transfer, by Type USD Million (2017-2022)
  • Table 110. Canada Facial Fat Transfer, by Application USD Million (2017-2022)
  • Table 111. Canada Facial Fat Transfer, by Targeted Site USD Million (2017-2022)
  • Table 112. Canada Facial Fat Transfer, by Donor Site USD Million (2017-2022)
  • Table 113. Mexico Facial Fat Transfer, by Type USD Million (2017-2022)
  • Table 114. Mexico Facial Fat Transfer, by Application USD Million (2017-2022)
  • Table 115. Mexico Facial Fat Transfer, by Targeted Site USD Million (2017-2022)
  • Table 116. Mexico Facial Fat Transfer, by Donor Site USD Million (2017-2022)
  • Table 117. Company Basic Information, Sales Area and Its Competitors
  • Table 118. Company Basic Information, Sales Area and Its Competitors
  • Table 119. Company Basic Information, Sales Area and Its Competitors
  • Table 120. Company Basic Information, Sales Area and Its Competitors
  • Table 121. Company Basic Information, Sales Area and Its Competitors
  • Table 122. Company Basic Information, Sales Area and Its Competitors
  • Table 123. Company Basic Information, Sales Area and Its Competitors
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Facial Fat Transfer: by Type(USD Million)
  • Table 128. Facial Fat Transfer Microfat Grafting , by Region USD Million (2023-2028)
  • Table 129. Facial Fat Transfer Nanofat Grafting , by Region USD Million (2023-2028)
  • Table 130. Facial Fat Transfer Structural Fat Grafting , by Region USD Million (2023-2028)
  • Table 131. Facial Fat Transfer: by Application(USD Million)
  • Table 132. Facial Fat Transfer Hospitals and Surgical Centres , by Region USD Million (2023-2028)
  • Table 133. Facial Fat Transfer Dermatological Clinics , by Region USD Million (2023-2028)
  • Table 134. South America Facial Fat Transfer, by Country USD Million (2023-2028)
  • Table 135. South America Facial Fat Transfer, by Type USD Million (2023-2028)
  • Table 136. South America Facial Fat Transfer, by Application USD Million (2023-2028)
  • Table 137. South America Facial Fat Transfer, by Targeted Site USD Million (2023-2028)
  • Table 138. South America Facial Fat Transfer, by Donor Site USD Million (2023-2028)
  • Table 139. Brazil Facial Fat Transfer, by Type USD Million (2023-2028)
  • Table 140. Brazil Facial Fat Transfer, by Application USD Million (2023-2028)
  • Table 141. Brazil Facial Fat Transfer, by Targeted Site USD Million (2023-2028)
  • Table 142. Brazil Facial Fat Transfer, by Donor Site USD Million (2023-2028)
  • Table 143. Argentina Facial Fat Transfer, by Type USD Million (2023-2028)
  • Table 144. Argentina Facial Fat Transfer, by Application USD Million (2023-2028)
  • Table 145. Argentina Facial Fat Transfer, by Targeted Site USD Million (2023-2028)
  • Table 146. Argentina Facial Fat Transfer, by Donor Site USD Million (2023-2028)
  • Table 147. Rest of South America Facial Fat Transfer, by Type USD Million (2023-2028)
  • Table 148. Rest of South America Facial Fat Transfer, by Application USD Million (2023-2028)
  • Table 149. Rest of South America Facial Fat Transfer, by Targeted Site USD Million (2023-2028)
  • Table 150. Rest of South America Facial Fat Transfer, by Donor Site USD Million (2023-2028)
  • Table 151. Asia Pacific Facial Fat Transfer, by Country USD Million (2023-2028)
  • Table 152. Asia Pacific Facial Fat Transfer, by Type USD Million (2023-2028)
  • Table 153. Asia Pacific Facial Fat Transfer, by Application USD Million (2023-2028)
  • Table 154. Asia Pacific Facial Fat Transfer, by Targeted Site USD Million (2023-2028)
  • Table 155. Asia Pacific Facial Fat Transfer, by Donor Site USD Million (2023-2028)
  • Table 156. China Facial Fat Transfer, by Type USD Million (2023-2028)
  • Table 157. China Facial Fat Transfer, by Application USD Million (2023-2028)
  • Table 158. China Facial Fat Transfer, by Targeted Site USD Million (2023-2028)
  • Table 159. China Facial Fat Transfer, by Donor Site USD Million (2023-2028)
  • Table 160. Japan Facial Fat Transfer, by Type USD Million (2023-2028)
  • Table 161. Japan Facial Fat Transfer, by Application USD Million (2023-2028)
  • Table 162. Japan Facial Fat Transfer, by Targeted Site USD Million (2023-2028)
  • Table 163. Japan Facial Fat Transfer, by Donor Site USD Million (2023-2028)
  • Table 164. India Facial Fat Transfer, by Type USD Million (2023-2028)
  • Table 165. India Facial Fat Transfer, by Application USD Million (2023-2028)
  • Table 166. India Facial Fat Transfer, by Targeted Site USD Million (2023-2028)
  • Table 167. India Facial Fat Transfer, by Donor Site USD Million (2023-2028)
  • Table 168. South Korea Facial Fat Transfer, by Type USD Million (2023-2028)
  • Table 169. South Korea Facial Fat Transfer, by Application USD Million (2023-2028)
  • Table 170. South Korea Facial Fat Transfer, by Targeted Site USD Million (2023-2028)
  • Table 171. South Korea Facial Fat Transfer, by Donor Site USD Million (2023-2028)
  • Table 172. Taiwan Facial Fat Transfer, by Type USD Million (2023-2028)
  • Table 173. Taiwan Facial Fat Transfer, by Application USD Million (2023-2028)
  • Table 174. Taiwan Facial Fat Transfer, by Targeted Site USD Million (2023-2028)
  • Table 175. Taiwan Facial Fat Transfer, by Donor Site USD Million (2023-2028)
  • Table 176. Australia Facial Fat Transfer, by Type USD Million (2023-2028)
  • Table 177. Australia Facial Fat Transfer, by Application USD Million (2023-2028)
  • Table 178. Australia Facial Fat Transfer, by Targeted Site USD Million (2023-2028)
  • Table 179. Australia Facial Fat Transfer, by Donor Site USD Million (2023-2028)
  • Table 180. Rest of Asia-Pacific Facial Fat Transfer, by Type USD Million (2023-2028)
  • Table 181. Rest of Asia-Pacific Facial Fat Transfer, by Application USD Million (2023-2028)
  • Table 182. Rest of Asia-Pacific Facial Fat Transfer, by Targeted Site USD Million (2023-2028)
  • Table 183. Rest of Asia-Pacific Facial Fat Transfer, by Donor Site USD Million (2023-2028)
  • Table 184. Europe Facial Fat Transfer, by Country USD Million (2023-2028)
  • Table 185. Europe Facial Fat Transfer, by Type USD Million (2023-2028)
  • Table 186. Europe Facial Fat Transfer, by Application USD Million (2023-2028)
  • Table 187. Europe Facial Fat Transfer, by Targeted Site USD Million (2023-2028)
  • Table 188. Europe Facial Fat Transfer, by Donor Site USD Million (2023-2028)
  • Table 189. Germany Facial Fat Transfer, by Type USD Million (2023-2028)
  • Table 190. Germany Facial Fat Transfer, by Application USD Million (2023-2028)
  • Table 191. Germany Facial Fat Transfer, by Targeted Site USD Million (2023-2028)
  • Table 192. Germany Facial Fat Transfer, by Donor Site USD Million (2023-2028)
  • Table 193. France Facial Fat Transfer, by Type USD Million (2023-2028)
  • Table 194. France Facial Fat Transfer, by Application USD Million (2023-2028)
  • Table 195. France Facial Fat Transfer, by Targeted Site USD Million (2023-2028)
  • Table 196. France Facial Fat Transfer, by Donor Site USD Million (2023-2028)
  • Table 197. Italy Facial Fat Transfer, by Type USD Million (2023-2028)
  • Table 198. Italy Facial Fat Transfer, by Application USD Million (2023-2028)
  • Table 199. Italy Facial Fat Transfer, by Targeted Site USD Million (2023-2028)
  • Table 200. Italy Facial Fat Transfer, by Donor Site USD Million (2023-2028)
  • Table 201. United Kingdom Facial Fat Transfer, by Type USD Million (2023-2028)
  • Table 202. United Kingdom Facial Fat Transfer, by Application USD Million (2023-2028)
  • Table 203. United Kingdom Facial Fat Transfer, by Targeted Site USD Million (2023-2028)
  • Table 204. United Kingdom Facial Fat Transfer, by Donor Site USD Million (2023-2028)
  • Table 205. Netherlands Facial Fat Transfer, by Type USD Million (2023-2028)
  • Table 206. Netherlands Facial Fat Transfer, by Application USD Million (2023-2028)
  • Table 207. Netherlands Facial Fat Transfer, by Targeted Site USD Million (2023-2028)
  • Table 208. Netherlands Facial Fat Transfer, by Donor Site USD Million (2023-2028)
  • Table 209. Rest of Europe Facial Fat Transfer, by Type USD Million (2023-2028)
  • Table 210. Rest of Europe Facial Fat Transfer, by Application USD Million (2023-2028)
  • Table 211. Rest of Europe Facial Fat Transfer, by Targeted Site USD Million (2023-2028)
  • Table 212. Rest of Europe Facial Fat Transfer, by Donor Site USD Million (2023-2028)
  • Table 213. MEA Facial Fat Transfer, by Country USD Million (2023-2028)
  • Table 214. MEA Facial Fat Transfer, by Type USD Million (2023-2028)
  • Table 215. MEA Facial Fat Transfer, by Application USD Million (2023-2028)
  • Table 216. MEA Facial Fat Transfer, by Targeted Site USD Million (2023-2028)
  • Table 217. MEA Facial Fat Transfer, by Donor Site USD Million (2023-2028)
  • Table 218. Middle East Facial Fat Transfer, by Type USD Million (2023-2028)
  • Table 219. Middle East Facial Fat Transfer, by Application USD Million (2023-2028)
  • Table 220. Middle East Facial Fat Transfer, by Targeted Site USD Million (2023-2028)
  • Table 221. Middle East Facial Fat Transfer, by Donor Site USD Million (2023-2028)
  • Table 222. Africa Facial Fat Transfer, by Type USD Million (2023-2028)
  • Table 223. Africa Facial Fat Transfer, by Application USD Million (2023-2028)
  • Table 224. Africa Facial Fat Transfer, by Targeted Site USD Million (2023-2028)
  • Table 225. Africa Facial Fat Transfer, by Donor Site USD Million (2023-2028)
  • Table 226. North America Facial Fat Transfer, by Country USD Million (2023-2028)
  • Table 227. North America Facial Fat Transfer, by Type USD Million (2023-2028)
  • Table 228. North America Facial Fat Transfer, by Application USD Million (2023-2028)
  • Table 229. North America Facial Fat Transfer, by Targeted Site USD Million (2023-2028)
  • Table 230. North America Facial Fat Transfer, by Donor Site USD Million (2023-2028)
  • Table 231. United States Facial Fat Transfer, by Type USD Million (2023-2028)
  • Table 232. United States Facial Fat Transfer, by Application USD Million (2023-2028)
  • Table 233. United States Facial Fat Transfer, by Targeted Site USD Million (2023-2028)
  • Table 234. United States Facial Fat Transfer, by Donor Site USD Million (2023-2028)
  • Table 235. Canada Facial Fat Transfer, by Type USD Million (2023-2028)
  • Table 236. Canada Facial Fat Transfer, by Application USD Million (2023-2028)
  • Table 237. Canada Facial Fat Transfer, by Targeted Site USD Million (2023-2028)
  • Table 238. Canada Facial Fat Transfer, by Donor Site USD Million (2023-2028)
  • Table 239. Mexico Facial Fat Transfer, by Type USD Million (2023-2028)
  • Table 240. Mexico Facial Fat Transfer, by Application USD Million (2023-2028)
  • Table 241. Mexico Facial Fat Transfer, by Targeted Site USD Million (2023-2028)
  • Table 242. Mexico Facial Fat Transfer, by Donor Site USD Million (2023-2028)
  • Table 243. Research Programs/Design for This Report
  • Table 244. Key Data Information from Secondary Sources
  • Table 245. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Facial Fat Transfer: by Type USD Million (2017-2022)
  • Figure 5. Global Facial Fat Transfer: by Application USD Million (2017-2022)
  • Figure 6. South America Facial Fat Transfer Share (%), by Country
  • Figure 7. Asia Pacific Facial Fat Transfer Share (%), by Country
  • Figure 8. Europe Facial Fat Transfer Share (%), by Country
  • Figure 9. MEA Facial Fat Transfer Share (%), by Country
  • Figure 10. North America Facial Fat Transfer Share (%), by Country
  • Figure 11. Global Facial Fat Transfer share by Players 2022 (%)
  • Figure 12. Global Facial Fat Transfer share by Players (Top 3) 2022(%)
  • Figure 13. Global Facial Fat Transfer share by Players (Top 5) 2022(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Allergen (Ireland) Revenue, Net Income and Gross profit
  • Figure 16. Allergen (Ireland) Revenue: by Geography 2022
  • Figure 17. Ranfac Corp. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Ranfac Corp. (United States) Revenue: by Geography 2022
  • Figure 19. Galderma (Switzerland) Revenue, Net Income and Gross profit
  • Figure 20. Galderma (Switzerland) Revenue: by Geography 2022
  • Figure 21. Cytori therapeutics (United States) Revenue, Net Income and Gross profit
  • Figure 22. Cytori therapeutics (United States) Revenue: by Geography 2022
  • Figure 23. Medikan International Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Medikan International Inc. (United States) Revenue: by Geography 2022
  • Figure 25. Alma Laser (Israel) Revenue, Net Income and Gross profit
  • Figure 26. Alma Laser (Israel) Revenue: by Geography 2022
  • Figure 27. MediNordic (Denmark) Revenue, Net Income and Gross profit
  • Figure 28. MediNordic (Denmark) Revenue: by Geography 2022
  • Figure 29. Human Med AG (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Human Med AG (Germany) Revenue: by Geography 2022
  • Figure 31. Sinclair Pharma (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. Sinclair Pharma (United Kingdom) Revenue: by Geography 2022
  • Figure 33. DMS Biotech (United States) Revenue, Net Income and Gross profit
  • Figure 34. DMS Biotech (United States) Revenue: by Geography 2022
  • Figure 35. Global Facial Fat Transfer: by Type USD Million (2023-2028)
  • Figure 36. Global Facial Fat Transfer: by Application USD Million (2023-2028)
  • Figure 37. South America Facial Fat Transfer Share (%), by Country
  • Figure 38. Asia Pacific Facial Fat Transfer Share (%), by Country
  • Figure 39. Europe Facial Fat Transfer Share (%), by Country
  • Figure 40. MEA Facial Fat Transfer Share (%), by Country
  • Figure 41. North America Facial Fat Transfer Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Allergen (Ireland)
  • Ranfac Corp. (United States)
  • Galderma (Switzerland)
  • Cytori therapeutics (United States)
  • Medikan International Inc. (United States)
  • Alma Laser (Israel)
  • MediNordic (Denmark)
  • Human Med AG (Germany)
  • Sinclair Pharma (United Kingdom)
  • DMS Biotech (United States)
Additional players considered in the study are as follows:
Anthony Products, Inc. (United States) , Genesis Biosystems, Inc. (United States) , Integra LifeSciences Corporation (United States)
Select User Access Type

Key Highlights of Report


Jun 2023 215 Pages 53 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Facial Fat Transfer Market are by type [Microfat Grafting, Nanofat Grafting and Structural Fat Grafting], by end use application [Hospitals and Surgical Centres and Dermatological Clinics].
The Facial Fat Transfer Market is gaining popularity and expected to see strong valuation by 2028.
  • Increasing Demand for Facial Fat Transfer in Thirty Age and Older Population
  • Surge for Face Countering As a Fastest Growing Cosmetic Procedure
  • Higher Request for Non-Invasive Procedure
  • Dermatologist Inclined Towards Learning Facial Fat Transfer Procedures

Know More About Global Facial Fat Transfer research Report?